Roth MKM analyst Scott Stember reiterated a Buy rating on Brunswick (BC – Research Report) today and set a price target of $85.00. The ...
Roth Mkm restated their buy rating on shares of TriSalus Life Sciences (NASDAQ:TLSI – Free Report) in a research report ...
Roth MKM keeps a Buy rating on Imax (IMAX) with a $28 price target after the company signed an exclusive, worldwide deal with ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 37.32% ...
Fintel reports that on December 18, 2024, Roth MKM initiated coverage of U.S. Gold (NasdaqCM:USAU) with a Buy recommendation. As of December 3, 2024, the average one-year price target for U.S ...
https://www.tipranks.com/news/the-fly/anavex-price-target-raised-to-42-from-40-at-h-c-wainwright Roth MKM lowered the firm’s price target on CervoMed (CRVO) to $4 ...
Replimune Group Inc (REPL) stock saw a modest uptick, ending the day at $11.85 which represents a slight increase of $1.71 or 16.86% from the prior close of $10.14. The stock opened at $12.6 and ...
Roth MKM raised the firm’s price target on Axis Capital (AXS) to $110 from $90 and keeps a Buy rating on the shares. The firm notes that while it was early in calling the re-underwriting change ...
Roth MKM analyst Matt Koranda maintained a Hold rating on AMMO (POWW – Research Report) today and set a price target of $1.75. The company’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback